GREY:IMVIF - Post by User
Comment by
qwerty22on Mar 02, 2021 4:30pm
190 Views
Post# 32697860
RE:Vaccines
RE:Vaccines One reason for not going full steam in RSV is it's actually a very difficult indication to get over the line, it's a biotech graveyard. We should be grateful they are cautious there. Sure risk somebody else's cash on it but not IMV's.
cribbons wrote:
Great article,
NOVAVAX just failed their Phase 3 RSV clinical trial. Fred looking for a vaccine partner. March is going to be busy.